In a study of lung cancer, the expression of paxillin in cancer tissue was higher than in normal lung tissue, and the somatic mutation rate was 9.4%, of which the most common point mutation (A127T) enhanced the growth and invasion ability of lung cancer cells [23]. Here, PXN is linked to lung carcinoma.